Sara Ferraro
Pisa, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Possible underdiagnosis of ulcerative colitis in tertiary care can affect medication use and access to healthcare facilities.
Journal: Frontiers in immunology
Published: August 27, 2025
Signals of Possibly Persistent Gustatory, Olfactory and Auditory Adverse Drug Reactions to Antibiotic Drugs: A Disproportionality Analysis Using the EudraVigilance Database.
Journal: Drug safety
Published: October 17, 2024
Lessons learnt from the preclinical discovery and development of ensitrelvir as a COVID-19 therapeutic option.
Journal: Expert opinion on drug discovery
Published: October 13, 2023
Potential missed diagnoses of Crohn's disease in tertiary care: impact on drug utilization and healthcare facilities use.
Journal: European journal of gastroenterology & hepatology
Published: September 19, 2023
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy.
Journal: Frontiers in pharmacology
Published: June 22, 2023
Comment on: "Deliberate Self-Poisoning: Real-Time Characterisation of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System".
Journal: Drug safety
Published: June 18, 2023
Signal management and risk minimization strategy: a case study on obinutuzumab and non-overt disseminated intravascular coagulation.
Journal: Frontiers in drug safety and regulation
Published: March 27, 2023
Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: February 23, 2023
Tixagevimab + cilgavimab against SARS-CoV-2: the preclinical and clinical development and real-world evidence.
Journal: Expert opinion on drug discovery
Published: January 17, 2023
Cases of acquired hemophilia A following COVID-19 vaccines: Cogent safety signal or possible reporting/detection bias? Preliminary evidence from Tuscany, Italy.
Journal: Pharmacoepidemiology and drug safety
Published: November 11, 2022
Preclinical discovery and development of the casirivimab + imdevimab cocktail for the treatment of novel coronavirus infection: the rise and fall.
Journal: Expert opinion on drug discovery
Published: April 01, 2022
Trajectories of Adherence to Biologic Disease-Modifying Anti-Rheumatic Drugs in Tuscan Administrative Databases: The Pathfinder Study.
Journal: Journal of clinical medicine
Published: November 12, 2021
Last Updated: 09/26/2026